Johnson & Johnson AIDS Vaccine Protects Monkeys in Study
Published: Jan 06, 2012
An experimental vaccine developed by a Johnson & Johnson (JNJ) unit and the U.S. military protected monkeys against an animal version of the AIDS virus, a study found. Monkeys that got the vaccine were as much as 83 percent less likely than those that got a dummy shot to become infected with simian immunodeficiency virus, or SIV, researchers from Harvard Medical School and the U.S. Military HIV Research Program said in a study published online in the journal Nature today. They now plan to test the vaccine in humans.